Immutep Ltd ADR (IMMP) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.74
• Market Cap: $410.67M
• EPS: $-0.42
• 52-Week High: $3.32
• 52-Week Low: $1.32

Market Sentiment

Immutep Ltd ADR currently has a Neutral sentiment score of 0.02.

About Immutep Ltd ADR

Immutep Ltd ADR is a biotechnology company headquartered in Sydney, Australia, specializing in the development of innovative immunotherapy treatments for cancer and autoimmune diseases. The firm is advancing its lead product candidates designed to modulate immune responses, thereby enhancing the body's capacity to combat tumors. With a promising pipeline and established strategic partnerships, Immutep aims to transform therapeutic approaches in oncology, positioning itself to capitalize on su...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Immutep Ltd ADR and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does IMMP pay dividends?

Immutep Ltd ADR (IMMP) does not currently pay a regular dividend.

What is IMMP's market cap?

Immutep Ltd ADR (IMMP) has a market capitalization of $410.67M with a current stock price of $2.74.